KATELYN MILAM: Open Payments
NPI 1861976417 · HUNTERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 18 payments from 7 companies in 2025. Trend: 2023 $1,163 · 2024 $915 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $319 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
Products named: MAVYRET, JARDIANCE, ELIQUIS, NUZYRA, LifeVest, ZERBAXA, Ozempic, UBRELVY.
Industry payments across NC — which companies pay providers there.
